6Weinstein DM, Mihm M J, Bauer JA. Cardiac Peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther, 2000,294:396-401.
7Sazuka Y, Tanizawa H, Takino Y. Effect of adriamycin on DNA,RNA and protein biosynthesis in mouse issues, in connection with its cardiotoxity. Jpn J cancer Res. 1992,80:1000.
8Reveneau S, Arnould L, Jolimoy G, et al, Nitric oxide Synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lan invest, 1999,79:1215-1225.
9Bonfoco E, Kraine D. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methylD-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci, 1995,92:7162-7166.
10Francis GS. Pathophysiology of chronic heart failure[ J]. Am J Med, 2001,110 (Suppl 7A): 37S- 46S.
3Floyd JD, Nguyen DT, Lobins RL. Cardiotoxicity of cancer therapy. J Clin Oncol, 2005 ;23(30) :7685-7696.
4Kim SY, Kim S J, Kim B J, et al. Doxorubicin-induced reactive oxygen species generation and intraeellular Ca^2+ increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med, 2006 ; 38 ( 5 ) : 535-545.
5Nelson MA, Frishman WH, SeiterK, et al. Cardiovascular considerations with anthracycline use in patients with cancer. Heart Dis,2001 ;3 (3) :157-168.
6T jeerdsma GT, Meinardi MT, Graaf WTA, et al. Early detection of anthracycline-induced cardiotoxicity in asympomatie patients with normal left ventricular systolic function : autonomic versus echocardiographic variables. Heart,1999;81:419-423.
7Bu' Luck FA, Mott MG, Oakhill A, et al. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function,sysptoms and pathophy siology. Br Heart J, 1995; 74( 3 ) :340-350.
8Adamcova M, Simunek T, Kaiserova H, et al. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxity. Toxicology, 2007 ;237 (1-3) :218-228.
9Mir T S, Marohn S, Laer S, et al. Plasm concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive hertfailure. Pediatrics, 2002;110(6) :E76.
10Hobbs FD, Davis RC, Roalfe AK, et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure:cohort study in representative and high risk community populations. BMJ, 2002;324(7352) :1498.
